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ABSTRACT  A specific antibody against myosin light chain kinase (MLCK) was used to identify 
the presence of a Ca2+-calmodulin-activated MLCK in mouse T-lymphoma cells. With a double 
immunofluorescence technique, MLCK was determined to be accumulated directly under Con 
A-capped  structures  in  a  manner  similar  to  that  of  previously described  accumulation  of 
actomyosin. The lymphocyte MLCK was phosphorylated in the uncapped cell and, by immu- 
noprecipitation with a specific MLCK  antibody, was shown to  possess a  Mr of  130,000. The 
MLCK was also found  to constitute a major fraction  of  the  phosphoproteins present in  the 
plasma membrane associated-cytoskeleton. Myosin light chain kinase catalyzed the phospho- 
rylation  of  both  endogenous  lymphocyte  myosin  light chains and  those  from  smooth  and 
skeletal muscle. The enzyme activity was dependent on the presence of Ca2+-calmodulin and 
was  inhibited  by  the calmodulin-binding drug, trifluoperazine. These data  suggest that  the 
membrane-cytoskeleton-associated MLCK activity may be important in regulation of the actin- 
myosin contraction which is believed to be required for the collection of surface receptors into 
capped structures. 
Lymphocyte surface receptors will aggregate into a cap struc- 
ture  at one pole of the cell  in  an energy- and  temperature- 
dependent  manner upon the addition of external multivalent 
ligands such as lectins or antibodies (32, 33). Cytochemically, 
it  has  been  shown  that  intracellular  actin  and  myosin  are 
always concentrated underneath the cap (4-6). Several research 
groups have detected biochemicaUy the existence of an acto- 
myosin-containing cytoskeleton in the receptor-cap structures 
(12,  16, 23).  Therefore, it has been proposed that transmem- 
brane  linkages  occur between  the  actomyosin filaments  and 
the surface receptors that are required for the clustering of the 
surface receptors into caps via a  sliding filament mechanism 
analogous to that occurring during muscle contraction (4). 
Studies on both smooth muscle and nonmuscle cells indicate 
that actomyosin-mediated contraction is regulated by myosin 
light chain kinase which in turn is regulated by Ca2+-calmod- 
ulin (3,  14). In addition,  the phosphorylation of myosin light 
chain has been shown to enhance the actin-activated  Mg  ++- 
ATPase  of myosin which  produces  the  energy to  drive  the 
sliding filament contraction process (1, 30).  In what might be 
an analogous mechanism, the 20,000-dalton myosin light chain 
in lymphocytes is phosphorylated during surface receptor cap- 
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ping  (9).  It  has  also  been  shown  recently  that  the  capping 
process can be inhibited (7) by a drug, trifluoperazine (TFP or 
Stelazine), that binds to calmodulin in a Ca2+-dependent man- 
ner. Finally, the process is also directly regulated  in vitro by 
micromolar concentrations of Ca  2+ ion (10).  Together,  these 
observations support the contention that this nonmuscle con- 
tractile process is myosin light chain kinase-dependent (3). 
Using  an  immunocytochemical  method,  we  found  that 
myosin light chain kinase (MLCK) is accumulated preferen- 
tially under Concanavalin A (Con A)-induced caps. The lym- 
phocyte  light  chain  kinase  (MLCK)  is  associated  with  the 
plasma  membrane-derived  actomyosin-containing  cytoskele- 
ton. The identity of this enzyme has been assured  by immu- 
noprecipitation  of a  :~2P-labeled  130,000-Mr  protein  with  a 
specific MLCK antibody and the capability of the enzyme to 
catalyse the calmodulin-dependent phosphorylation of endog- 
enous lymphocyte, as well as exogenous smooth and skeletal 
muscle myosin light chains.  Consequently, we are proposing 
that  the  MLCK-mediated  phosphorylation  of myosin  light 
chain  in  response  to  Ca2+-calmodulin is  one  mechanism re- 
sponsible for the activation of contractile elements required for 
the aggregation of receptors into capped structures. 
793 MATERIALS  AND  METHODS 
Cells 
The mouse T-lymphoma cell line, AKR/J lymphoma cell line BW5147 (gift 
from  Dr.  R.  Hyman,  The  Salk Institute), was grown in  Dulbecco's modified 
Eagle's (DME) medium supplemented with  10% heat-inactivated horse serum 
(Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) at 37°C 
in 5% CO2/95% air. 
A n  tibodies 
Rabbit anti-chicken gizzard MLCK  and  rabbit anti-human uterus  smooth 
muscle myosin were prepared according to the procedures described previously 
(19, 30. 
Induction of Capping by Fluorescein-conjugated 
Concanavalin A (FI-Con A) 
Cells stained for their initial  surface Con-A distribution were first washed with 
DME and fixed with 2% paraformaldehyde in 0.1 M PBS (pH 7.4) for 30 min at 
0°C.  Both  prefixed  and  unfixed cell suspensions (~1  x  l07  cells/ml) were 
incubated with Fl-Con A (50 pg/m[) at 0°C for 30 rain. Unbound F1-Con A was 
subsequently removed by rinsing, and cells were incubated at room temperature 
for 15 rain. In the case of prefixed cells, Con-A receptors were immobilized (Fig. 
I a), and unfixed ceils displayed a typical cap structure (Fig. I c). 
Drug Effect on Surface Con A Capping 
Unfixed cell suspensions (1 X  I07 cells/ml) were preincubated with 5 x  10  -~ 
M of trifluoperazine dihydrochloride (TFP) (Stelazine, Smith Kline and French 
Laboratories, Philadelphia, PA) (25, 26) for 30 min at room temperature. Drug- 
treated cells were subjected to  the  induction of Con-A  capping as described 
above. 
anti-chicken gizzard MLCK (100 #g/ml) followed by rhodamine-conjugated goat 
antibody against rabbit immunoglobulin. As a control, preabsorbed anti-MLCK- 
free immunoglobulin was used instead of anti-MLCK antibodies. No  MLCK 
staining was detected in the control samples. 
The flourescein- and rhodamine-labeled samples were examined in a  Zeiss 
photomicroscope with a x  40 oil immersion lens and an epiilluminator. Fluores- 
cein and rhodamine fluorescences were excited with an Osram HBO 50-W bulb 
using  filter combination CZ487710  and  CZ  487714,  respectively. Ceils were 
photographed with Kodak Plus-x film. 
Radioactive Labeling for 
Cellular Phosphoproteins 
Cel/suspensions (1  x  106 cells/ml) were washed with phosphate-free DME 
and labeled with 0.1  mCi 32p (Hs32po4, carrier free, ICN) for 30 rain at room 
temperature. Phosphorylation was terminated by adding an excess (10 vol) of 
unlabeled 0.1 M PBS at 0°C. 
Plasma Membrane Isolation 
Plasma membrane fractions were isolated  by the method described by Johnson 
and Bourne (20). 32P-labeled cells were washed twice with Dulbecco's phosphate- 
buffer medium and resuspended at a density of 107 cells/ml in 20 mM HEPES, 
2 mM  MgCI~,  1 mM EDTA,  1 mM 2-mercaptoethanol, pH  7.4,  at 4°C.  Ceils 
were disrupted with a  Dounce homogenizer. The lysate was centrifuged at 750 
g,~ for  5  min and  the  supernatant  fluid was centrifuged in  an  SW50.1  rotor 
(Beckman Instruments, Inc., Palo Alto, CA) at 43,000  g,v for 20 min. The pellet 
was resuspended in 10"7o  sucrose (wt/wt) in the same buffer and centrifuged in a 
Beckman  SW  50.1  rotor  at  100,000  ga~  for  80  rain.  The  plasma membrane 
fraction,  which sediments between  30%  and  40%  sucrose,  was  collected and 
washed with Dulbecco's PBS.  Surface markers such as T200,  Thy-1, and glyco- 
protein (gp) 69/71  have been reported to be preferentially concentrated in this 
particular plasma membrane fraction by immunoprecipitation techniques (8). 
Double Immunofluorescence Microscopy 
Both capped and uncapped cells were rendered permeable by using either 
frozen sections (5) or methanol/acetone treatment (11)  and stained with rabbit 
Nonidet P-40 (NP-40) Extraction 
The  isolated plasma membranes  (with  or  without  :~P-labeling) were  first 
resuspended in PPI solution (10 mM sodium phosphate buffer, pH 7.2, containing 
I  mM  phenylmethylsulphonyl fluoride (PMSF),  and  10 mM  iodoacetamide). 
Nonionic  detergent  extraction was  carried  out  according  to  the  procedures 
described previously (27) by adding 1% NP-40 to the plasma membrane prepa- 
ration in PPI solution with vigorous vortexing. Protein concentration was held 
constant at 0.5  mg/ml. The  samples were incubated at 0°C  for 20 min with 
frequent vortexing and then centrifuged for 45 rain at 100,000 gay. After centrif- 
ugation, the  pellets (i.e.,  NP-40-insoluble fraction) were collected for  further 
biochemical and cytochemical analysis. 
FIGURE  1  Simultaneous  localization  of  surface  Con-A  receptors 
and intracellular MLCK.  (a-b)  Prefixed cells stained with  FI-Con A 
(a) followed by either frozen thick sectioning or acetone treatment 
and rabbit anti-MLCK plus rhodamine (Rh)-goat anti-rabbit immu- 
noglobulin,  a shows FI-Con A staining of the same cell stained for 
MLCK  in  b.  (c-d)  Unfixed  cells  were  induced  to  form  cap  by 
treatment with  FI-Con A  (c)  followed by staining with  rabbit anti- 
MLCK plus Rh-goat anti-rabbit immunoglobulin as described above 
(d).  c shows the Con A cap on the same cell stained for MLCK as 
shown  in  d.  (e-f)  In  the  presence of TFP  (Stelazine), cells  were 
treated  with  FI-Con  A  (e)  followed  by  labeling  with  rabbit  anti- 
MLCK and Rh-goat anti-rabbit immunoglobulin  (f)  as mentioned 
above, e represents the FI-Con A staining on the same cell labeled 
for MLCK as shown in  f. (a-f)  X  1,500. 
Imm  unoprecipita tion 
~'zP-labeled total plasma membranes or cytosk¢letal fractions isolated from 
uncapped cells (l ×  10  a ceils) were incubated with 0.1% NP-40 in 10 mM Tris- 
HCL pH 8.0, at 4°C for 30 rain. The NP-40-treated membrane or cytoskeletal 
fractions were then incubated with either rabbit anti-MLCK or anti-MLCK-free 
(preabsorbed) antisera (100 pg/ml) at 4°C for 30 min. Subsequently, goat anti- 
rabbit immunoglobulin (200 ~g/ml) was added to the samples at 4°C for 30 rain 
to precipitate the immune complex. The immunoprecipitates were obtained by 
cantrifugation at 12,000 gay for 10 rain. Each precipitate was washed with PBS 
three times using the same centrifugation  procedure. The polypeptide composition 
and radioactivity  of the immunoprecipitates were determined by SDS PAGE and 
autoradiography, respectively. 
SDS PAGE and Radioactivity Analysis 
Electrophoresis was carried out on slab gels using the discontinuous buffer 
system described by Laemmli (24)  and an exponential polyacrylamide gel gra- 
dient (7.0-17.5%)  (21). All radioactively labeled samples (including total plasma 
membranes, NP-40 insoluble fractions of plasma membranes isolated from '~P- 
labeled cells and  asP-labeled immunoprecipitates) were  dissolved in a  buffer 
containing 2% SDS, 0.1 M dithiothreitol, 0.003% bromophenol blue, 20 mM Tris- 
HC1, pH 6.8, and heated at  100°C for 2 min. Approximately 125 pg of protein 
per sample was applied to the gel. Electrophoresis was carried out-at a constant 
current of 2  mA for  18 h  at room temperature, and the polypeptide banding 
pattern was revealed by staining with Coomassie Blue. The gels were then dried 
by vacuum, and  the  32P-labeled  dried gels were exposed to Kodak x-ray (X- 
Omat, XR-1) film. 
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The MLCK-assay procedures used in this study were generally the same as 
those described previously (19). The reaction mixture contained  crude enzyme 
preparations  (such as total  lymphoma plasma  membranes  or NP-40 insoluble 
cytoskeletal material),  20 mM KC1, 1 mM Mg acetate,  10  -4 M Ca  2÷ (pCa = 
-loglol0  -4 = 4.0, high Ca2÷), with or without the addition of myosin fight chains 
(e.g.,  18  mg/ml chicken  gizzard myosin  light chains  or skeletal  myosin light 
chains),  5  #M  calmodulin,  and  1 mM  y-32P-ATP (100-200  cpm/pmol). As 
controls, calmodulin  was eliminated  and 10  -4 M Ca  2÷ (pCa  =  4.0, high Ca  2÷) 
was replaced by 10  -a M Ca  ~÷ (pCa = -loglol0 a = 8.0, low Ca  2+) in the reaction 
mixture. In some cases, the enzyme assays were carried out in the presence of 5 
×  10  -~  M  trifluoperazine  (TFP,  Stelazine).  Reactions  were  initiated  by  the 
addition  of "/-32P-ATP (1CN Chemical and Radioisotope  Division, lrvine, CA) 
and incubated  for 5  min  at  30°C.  Myosin  light  chain phosphorylation  was 
assayed by the following three methods: (a) spotting 0.005 ml of  reaction mixture 
on Whatman 31 ET chromatography  paper followed by 10% trichloroacetic acid 
(TCA) rinses as described previously (19); (b) analyzing the reaction mixture with 
SDS PAGE,  cutting out and determining  the radioactive content of the bands 
corresponding  to myosin light chain  (20,000 Mr); (c) immunoprecipitating  the 
reaction mixture with rabbit anti-human uterus myosin antiserum (31) which has 
been previously determined  to cross-react with lymphocyte myosin light chain 
(9). Radioactivity  was  determined  in each  case  by scintillation  spectrometry 
following  solubllization  of the samples  in  Aquasol  (New  England  Nuclear, 
Boston, MA). 
Negative Staining Procedures for 
Electron Microscopy 
For negative staining, three successive drops of  either a solution of  0.1 M KCI, 
0.01 immidazole, pH 7.0, containing  intact plasma membranes or a  1% NP-40 
insoluble  fraction  of the  plasma  membranes  from  ceils  were  added  to  4% 
Formvar-coated  grids. Then three drops of I% uranyl acetate in water (pH 4.5) 
were apphed to the samples for 30 s and removed with filter paper (18). These 
negatively stained samples were examined in a Philips 300 electron microscope. 
RESULTS 
Double immunofluorescence staining of prefixed lymphocytes 
reveals that the surface Con-A  receptors are generally distrib- 
uted  uniformly  over  the  surface  of the  ceils  (Fig.  I a)  while 
intracellular myosin light chain kinase is diffusely distributed 
throughout the cytoplasm (Fig.  1 b) under the conditions used. 
However,  when  unfixed  cells  were  induced  to  form  capped 
structures (Fig.  I c), the intracellular  MLCK  was found to be 
concentrated under the Con-A cap (Fig.  I d). If trifluoperazine 
was added to cells during the capping reaction, then both the 
Con-A surface receptors (Fig.  1 e) and the intracellular MLCK 
(Fig.  l f)  remained uniformly distributed. The results shown in 
Fig.  l  support the contention that calmodulin may be related 
to the capping process (10, 22) and suggest that this regulatory 
molecule and MLCK  may be associated with the actomyosin- 
containing cytoskeleton required for Con-A capping. 
Fig. 2 a  shows a  micrograph of the plasma membrane  frac- 
tion  used  in  this  study.  The  fraction  contained  vesicles  of 
various sizes but no visual contamination by other membranous 
components such as those from nuclei, mitochondria, or rough 
endoplasmic  reticulum  was  apparent.  In  addition,  assays  for 
Na+/K + ATPase and 5'-nucleotidase revealed that the prepa- 
ration was enriched for plasma membranes by 20-fold. Analysis 
FIGURE  2  Negative staining and SDS PAGE analysis of plasma membranes and NP-40 insoluble fraction of the plasma membranes 
from  mouse T-lymphoma cells.  (a)  Isolated  total  plasma  membranes without  NP-40 treatment stained  with  uranyl  acetate,  x 
20,000. (b)  Polypeptide composition of total plasma membranes stained by Coomassie Blue. (c)  Polypeptide composition of N P-40 
insoluble  (cytoskeleton)  fraction  of  plasma  membranes stained  by Coomassie-Blue staining  (myosin  and  actin  together with  a 
couple of other polypeptides are the major components in this cytoskeleton material). (d)  NP-40 insoluble fractions cytoskeleton 
of the plasma membrane stained with uranyl acetate, x  40,000.  Molecular weight markers used in the study are in daltons: myosin, 
200,000; fl-galactosidase, 130,000;  lactoperoxidase, 78,000;  BSA, 68,000;  actin, 42,000;  Con A, 25,000. 
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30 bands detectable  by Coomassie-Blue staining.  An electron 
micrograph of the membrane-associated cytoskeletal complex 
(prepared by extraction of the plasma membranes with NP-40 
followed by centrifugation at 100,000 gay) is shown in Fig. 2 d. 
This fraction is composed primarily of 50-70-A actinlike fila- 
ment bundles (Fig. 2d).  Indeed,  the polypeptide composition 
of this  fraction  appears to be less complex (Fig.  2 c).  In this 
case, the major proteins are actin (42,000),  myosin heavy chain 
(200,000),  and a doublet at 240,000-260,000  which presumably 
represents  the  subunits  of the  spectrinlike  proteins  described 
by Glenney et al. (17). 
MLCK has been identified as a  130,000-dalton  polypeptide 
in several different type of cells (3,  19) and  can be phospho- 
rylated (2). Fig. 3 reveals an analysis of the protein components 
of both membrane and cytoskeletal fractions by autoradiogra- 
phy  after  metabolic  labeling  of lymphocytes with  32po4.  At 
least  12 major phosphorylated polypeptides are evident in the 
total plasma membrane fraction (Fig. 3 a), but only four major 
phosphorylated polypeptides (at 220,000,  180,000,  130,000, and 
36,000)  are present in the cytoskeletal fraction (Fig. 3 b). The 
130,000  protein in the plasma membrane has been identified 
as a  phosphorylated form of MLCK by immunoprecipitation 
(Fig. 3 c) with a specific MLCK antibody. Similar results were 
obtained with the cytoskeleton fraction (data not shown). The 
specificity of the immunoprecipitation  was established by the 
fact that an antiserum preabsorbed  with MLCK precipitated 
TABLE  I 
Assays for MLCK Activity 
pmol 32P-in- 
corporated/ 
Substrates  Conditions  min/mg MLC 
Skeletal muscle 
Smooth muscle 
Lymphocytes 
pCa 8.0  100 
pCa 4.0 +  caimodulin  302 
pCa 4.0 +  TFP  85 
3Ca 8.0  106 
~Ca 4.0 +  calmodulin  406 
3Ca 4.0 +  TFP  100 
3Ca 8.0  186 
~Ca 4.0 +  calmodulin  809 
~Ca 4.0 +  TFP  70 
Enzyme reactions were carried out under various conditions such  as (a) low 
Ca  2+  (pCa =  8.0, 10  -8 M, Ca2+);  or (b) high Ca  2+  (pCa =  4.0, 10  -4 M, Ca  2÷) 
plus calomodulin; or (c) in the presence of 5 x  I0 -s M  trifluoperazine (TFP) 
(Stelazine)  and  high  Ca  2+  (pCa =  4.0, 10  4 M,  Ca  2+)  using  NP-40  insoluble 
(cytoskeleton) fraction from mouse T-lymphoma cells as crude MLCK sources. 
Reactions were initiated  by the addition  of -r'-32P-ATP and  incubated  for 5 
min  at  30~C. The  ability  of  lymphocyte  MLCK  to  phosphorylate  skeletal 
muscle,  smooth  muscle  myosin  light  chains,  and  lymphocyte  myosin  light 
chain was measured according to the procedures described  in Materials and 
Methods. In  this particular case, the level of myosin light chain phosphoryl- 
ation was assayed  by immunoprecipitating  the MLCK reaction  product with 
rabbit antimyosin followed by SDS PAGE analysis.  The bands corresponding 
to  myosin  light  chain  (20,000  daltons)  were cut  out  and  radioactivity was 
determined  using  Aquasol  and  a  liquid  scintillation  counter  as  described 
previously (9). Each number represents the average of three experiments with 
standard deviation less than ±5%. 
FIGURE  3  Autoradiograms of a2P-labeled  proteins from  mouse T- 
lymphoma cells.  Cells were metabolically labeled with  carrier free 
H332PO4 as described in  Materials and  Methods.  (a)  Total  plasma 
membrane  (in  the absence of  NP-40).  (b)  NP-40  insoluble  (cyto- 
skeleton) fraction of plasma membranes. (c)  Anti-MLCK immuno- 
precipitable from  plasma membrane (similar results  were obtained 
with  the cytoskeleton fraction.)  (d)  Anti-MLCK-free  (preabsorbed 
reagent)/(nonspecific) immunoprecipitates from plasma membrane 
(similar results were obtained with cytoskeleton fraction). Molecular 
weight markers used  in this study were the same as those described 
in Fig. 2. 
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neither the 130,000 protein nor any of the other phosphorylated 
proteins (Fig. 3 d). 
Further confirmation of the presence of MLCK was obtained 
by carrying out functional assays for the enzyme as described 
in  Materials  and  Methods.  Table  I  shows  that  membrane- 
cytoskeletal fractions contain a Ca~+-calmodulin-activated (tri- 
fluoperazine-sensitive) MLCK activity. The enzyme is capable 
of phosphorylation of the endogenous lymphocyte light chains 
(Table  I)  as  well  as  that  of exogenously  added  light  chains 
from smooth muscle (Table I) and  skeletal muscle (Table  I). 
The  MLCK  activity appears to  be approximately 2-2.5-fold 
less when  assayed with  the  exogenous  myosin light  chain  as 
substrate.  Two possible explanations for this reduction  in ac- 
tivity could be either that the exogenous substrates are phos- 
phorylated and/or immunoprecipitated less efficiently than the 
endogenous lymphocyte myosin light chains or that the exog- 
enous  substrate  is competing with  the  endogenous  substrate. 
However,  regardless  of the  source  of substrate,  the  specific 
activity  of this  enzyme  is  seven-  to  eightfold  greater  in  the 
cytoskeletal  fraction  as  compared  to  the  total  plasma  mem- 
brane (data not shown). This enrichment of MLCK activity in 
the actomyosin complex provides additional  evidence for the 
involvement of this  enzyme in  the  regulation  of lymphocyte 
receptor capping. 
DISCUSSION 
Both  cytochemical  and  biochemical  data  now  indicate  that 
actomyosin-containing  structures  are  closely  associated  with 
cap formation (4-6,  12,  16, 23).  Such observations are compat- 
ible with the possibility that the force-generating mechanisms 
involved may be similar to those that occur during other motile 
events in smooth and nonmuscle cells (14). These mechanisms 
involve the activation of actomyosin ATPase by the phospho- rylation  of the  20,000  Mr  myosin  light  chain  (1,  30).  This 
activation is catalyzed by MLCK in a  manner that  requires 
Ca'~+-calmodulin  (29).  lntracellular  concentrations  of Ca  2+, 
calmodulin and ATP are all required for the capping of Con- 
A-receptors in lymphocytes (10). Calmodulin has been shown 
to co-cap with  Con-A receptors (28)  and myosin light chain 
phosphorylation occurs during the capping event (9). We report 
here that the Final component of the putative contractile system, 
the MLCK, also co-caps with Con-A receptors and is, therefore, 
in the proper locale to catalyze the generation of force. 
MLCK was demonstrated to represent  a component of the 
insoluble cytoskeletal network prepared by detergent treatment 
of lymphocyte plasma membranes. The enzyme was phospho- 
rylated metabolically in uncapped cells  and  immunoprecipi- 
tated  by an antibody prepared  against chick gizzard MLCK 
(19). For now the regulatory mechanism involved in the phos- 
phorylation  of MLCK  in  intact  lymphocytes  is  unknown. 
Consequently, under these conditions, the light chain of myosin 
does not appear to be phosphorylated as analyzed by autora- 
diographic method (Fig.  3).  These results are consistent with 
the demonstration that phosphorylation of the kinase  lowers 
the activity of the enzyme (13). The activity of the enzyme was 
demonstrated using both endogenous lymphocyte myosin light 
chains and exogenously supplied substrate isolated from both 
smooth  and  skeletal  muscle.  The  MLCK  activity  was  both 
Ca  2+  and  calmodulin  dependent  and  was  inhibited  by  the 
calmodulin-binding drug, trifluoperazine. By activity measure- 
ment, MLCK is enriched in the cytoskeletal preparation seven- 
to eightfold compared to the plasma membrane. In addition to 
MLCK,  the  50-70-]~  Fdaments  in  the  insoluble  cytoskeletal 
material  contained  actin,  myosin, and  two high Mr proteins 
(240,000-260,000)  that  presumably represent  the  spectrinlike 
molecules described by Glenney et al. (17). These proteins bind 
both actin and calrnodulin and may therefore be involved in 
the cross-linking of specific components involved in cap for- 
mation. The energy required for such interactions could also 
be derived  from actomyosin-catalyzed ATP hydrolysis in re- 
sponse  to  calmodulin-activated  MLCK.  Further  evidence  in 
support of the regulatory role of MLCK in Con-A cap forma- 
tion is presented elsewhere (22). 
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